Diffuse Large B-Cell Lymphoma (DLBCL) Latest Advances

Integrating Epstein-Barr virus (EBV) status into diffuse large B cell lymphoma (DLBCL) genetics.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Suspected Secondary Intraocular Lymphoma With Choroidal Involvement Following Testicular Diffuse Large B-cell Lymphoma: A Case Report.

Journal: Cureus

Published: April 07, 2026

Cost-efficiency modeling of conversion to biosimilar rituximab-based R-CHOP in diffuse large B-cell lymphoma in medicare.

Journal: Journal of medical economics

Published: April 06, 2026

Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma: Real-World Data From Saudi Arabia.

Journal: JCO global oncology

Published: April 03, 2026

Isoform-Specific Functions of p73 Drive Survival and Chemoresistance in Diffuse Large B-Cell Lymphoma.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Corrigendum to "Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL" [Mater. Today Bio (35) 102267].

Journal: Materials today. Bio

Published: April 02, 2026

Primary sinonasal DLBCL: High prevalence of MCD subtype and CNS risk.

Journal: Annals of the Academy of Medicine, Singapore

Published: April 01, 2026

CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS).

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

BPI26-014: Predictors of Advanced-Stage DLBCL at Diagnosis: Logistic Regression Analysis Highlights High Risk Populations With Inclusion of Demographic and Anatomic Risk Factors.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: April 01, 2026

Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adults.

Journal: Hematology (Amsterdam, Netherlands)

Published: April 01, 2026

CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: April 01, 2026

EPR26-178: Disease-Specific Mortality in DLBCL: Cox Model Reveals Superior Prognostic Value Over Age-Based Risk Assessments.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 31, 2026

Diffuse Large B-Cell Lymphoma (DLBCL) Latest Advances

Find the Latest Research About Diffuse Large B-Cell Lymphoma (DLBCL)

Integrating Epstein-Barr virus (EBV) status into diffuse large B cell lymphoma (DLBCL) genetics.

Integrating Epstein-Barr virus (EBV) status into diffuse large B cell lymphoma (DLBCL) genetics.

Suspected Secondary Intraocular Lymphoma With Choroidal Involvement Following Testicular Diffuse Large B-cell Lymphoma: A Case Report.

Suspected Secondary Intraocular Lymphoma With Choroidal Involvement Following Testicular Diffuse Large B-cell Lymphoma: A Case Report.

Cost-efficiency modeling of conversion to biosimilar rituximab-based R-CHOP in diffuse large B-cell lymphoma in medicare.

Cost-efficiency modeling of conversion to biosimilar rituximab-based R-CHOP in diffuse large B-cell lymphoma in medicare.

Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma: Real-World Data From Saudi Arabia.

Clinical Characteristics and Outcome of Diffuse Large B-Cell Lymphoma: Real-World Data From Saudi Arabia.

Isoform-Specific Functions of p73 Drive Survival and Chemoresistance in Diffuse Large B-Cell Lymphoma.

Isoform-Specific Functions of p73 Drive Survival and Chemoresistance in Diffuse Large B-Cell Lymphoma.

Corrigendum to "Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL" [Mater. Today Bio (35) 102267].

Corrigendum to "Tumor-homing exosomes enable targeted delivery of siRNA and isoimperatorin for overcoming BTK inhibitor resistance in DLBCL" [Mater. Today Bio (35) 102267].

Primary sinonasal DLBCL: High prevalence of MCD subtype and CNS risk.

Primary sinonasal DLBCL: High prevalence of MCD subtype and CNS risk.

CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS).

CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS).

BPI26-014: Predictors of Advanced-Stage DLBCL at Diagnosis: Logistic Regression Analysis Highlights High Risk Populations With Inclusion of Demographic and Anatomic Risk Factors.

BPI26-014: Predictors of Advanced-Stage DLBCL at Diagnosis: Logistic Regression Analysis Highlights High Risk Populations With Inclusion of Demographic and Anatomic Risk Factors.

Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adults.

Survival and prognostic features of early-stage diffuse large B-cell lymphoma in older adults.

CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate.

CD83 as a novel prognostic biomarker for diffuse large B-cell lymphoma arising in immune deficiency/dysregulation among rheumatoid arthritis patients treated with methotrexate.

EPR26-178: Disease-Specific Mortality in DLBCL: Cox Model Reveals Superior Prognostic Value Over Age-Based Risk Assessments.

EPR26-178: Disease-Specific Mortality in DLBCL: Cox Model Reveals Superior Prognostic Value Over Age-Based Risk Assessments.